Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons.

Author: BeltrameA, CarosiG, CasaliniC, CiravoloG, ForleoM A, GraifemberghiS, GullettaM, MatteelliA, TedoldiS

Paper Details 
Original Abstract of the Article :
BACKGROUND: Treatment options for anogenital warts in patients with HIV-1 are unsatisfactory because they fail to eradicate latent human papillomavirus. GOAL: To determine tolerability and efficacy of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected patients...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/00007435-200106000-00007

データ提供:米国国立医学図書館(NLM)

Tackling the Tough Nut of Anogenital Warts in HIV Patients

The field of HIV research constantly faces the challenge of finding effective treatments for complications like anogenital warts. These pesky warts are caused by the human papillomavirus (HPV), and the trouble is, it can hide out in your body, making it difficult to eradicate completely. This study set out to investigate the effectiveness and tolerability of topical 1% cidofovir cream in treating these warts in HIV-infected individuals. The researchers employed a randomized, placebo-controlled, single-blind, crossover pilot study, where participants were randomly assigned to either the cidofovir cream or a placebo for two weeks, followed by a two-week observation period. After this, the groups switched treatments.

The results indicated that cidofovir cream was significantly more effective than the placebo in reducing the size of the warts. Around 58% of patients using cidofovir saw a reduction of over 50% in the total wart area, while no placebo regimen achieved this. However, the study did reveal a common side effect: local mucosal erosion occurred in 10 out of the 12 patients treated with cidofovir.

Cidofovir Cream: A Promising Option with a Side of Caution

This research suggests that cidofovir cream could be a valuable tool in the fight against anogenital warts in HIV patients. The study demonstrated its efficacy in reducing wart size, offering hope for improved treatment options. But, the common occurrence of local mucosal erosion serves as a reminder that we must carefully consider the potential side effects alongside the benefits.

Living with Anogenital Warts: A Balancing Act

Anogenital warts can be a real nuisance, but it's important to remember that they are treatable. If you're diagnosed with anogenital warts, it's crucial to talk to your doctor about the best treatment options for you, taking into account your individual health profile and risk factors. Don't hesitate to discuss your concerns and preferences with your healthcare provider.

Dr. Camel's Conclusion

Just like a camel navigating the vast desert, researchers are always searching for the best route to treat HPV-related complications. While cidofovir cream shows potential, the side effects remind us that the journey to effective treatment is complex. Always consult with your doctor to find the right path for you!

Date :
  1. Date Completed 2001-10-25
  2. Date Revised 2019-09-10
Further Info :

Pubmed ID

11403192

DOI: Digital Object Identifier

10.1097/00007435-200106000-00007

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.